Vulvodynia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women with vulvodynia symptons, for, at least 6 months Women with positive test for vulvodynia Women willing to participate and to accept and sign voluntarily, the consent term
Exclusion criteria
Exclusion criteria: Women who use intrauterine device Pregnancy Women who use pacemakers Women who have some sort of metal implant in the region of the lumbar spine or hip Women who have neoplasic diseases Women with acute infectious process in the vulvar region Chronic Immunosuppression Deformity of the spine or pelvis Genital ulcer Women on medications that may cause mucositis (eg prolonged use of antibiotics, immunomodulators, chemotherapeutics) Women with systemic or acute allergic framework (localized) Women who are known to have chronic degenerative disease (eg Acquired immunodeficiency syndrome, renal transplant, lupus, tuberculosis)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of pain during intercourse after tratamentro with interferential current evaluated by Visual Analog Scale, reported by the patient.;Improved sexual function score evaluated by the Female Sexual Function Index; Improvement in pain on examination evaluated by visual analog scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Improved intravaginal basal tone, the maximum force of contraction of the vaginal muscles, and the resistance of the vaginal muscles, assessed before and after treatment using electromyographic analysis (uV) and pressure (mmHg) with the device Miotool. | — |
Countries
Brazil
Contacts
Faculdade de Ciências Médicas - Universidade Estadual de Campinas